0000001961 2025-01-01 2025-09-30 0000001961 2026-05-08 0000001961 2025-09-30 0000001961 2024-12-31 0000001961 2024-01-01 2024-09-30 0000001961 2025-07-01 2025-09-30 0000001961 2024-07-01 2024-09-30 0000001961 us-gaap:CommonStockMember 2023-12-31 0000001961 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000001961 us-gaap:WarrantMember 2023-12-31 0000001961 us-gaap:RetainedEarningsMember 2023-12-31 0000001961 2023-12-31 0000001961 us-gaap:CommonStockMember 2024-03-31 0000001961 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000001961 us-gaap:WarrantMember 2024-03-31 0000001961 us-gaap:RetainedEarningsMember 2024-03-31 0000001961 2024-03-31 0000001961 us-gaap:CommonStockMember 2024-06-30 0000001961 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000001961 us-gaap:WarrantMember 2024-06-30 0000001961 us-gaap:RetainedEarningsMember 2024-06-30 0000001961 2024-06-30 0000001961 us-gaap:CommonStockMember 2024-12-31 0000001961 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000001961 us-gaap:WarrantMember 2024-12-31 0000001961 us-gaap:RetainedEarningsMember 2024-12-31 0000001961 us-gaap:CommonStockMember 2025-03-31 0000001961 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0000001961 us-gaap:WarrantMember 2025-03-31 0000001961 us-gaap:RetainedEarningsMember 2025-03-31 0000001961 2025-03-31 0000001961 us-gaap:CommonStockMember 2025-06-30 0000001961 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0000001961 us-gaap:WarrantMember 2025-06-30 0000001961 us-gaap:RetainedEarningsMember 2025-06-30 0000001961 2025-06-30 0000001961 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000001961 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000001961 us-gaap:WarrantMember 2024-01-01 2024-03-31 0000001961 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000001961 2024-01-01 2024-03-31 0000001961 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0000001961 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0000001961 us-gaap:WarrantMember 2024-04-01 2024-06-30 0000001961 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0000001961 2024-04-01 2024-06-30 0000001961 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0000001961 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0000001961 us-gaap:WarrantMember 2024-07-01 2024-09-30 0000001961 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0000001961 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0000001961 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0000001961 us-gaap:WarrantMember 2025-01-01 2025-03-31 0000001961 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0000001961 2025-01-01 2025-03-31 0000001961 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0000001961 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0000001961 us-gaap:WarrantMember 2025-04-01 2025-06-30 0000001961 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0000001961 2025-04-01 2025-06-30 0000001961 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0000001961 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0000001961 us-gaap:WarrantMember 2025-07-01 2025-09-30 0000001961 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0000001961 us-gaap:CommonStockMember 2024-09-30 0000001961 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0000001961 us-gaap:WarrantMember 2024-09-30 0000001961 us-gaap:RetainedEarningsMember 2024-09-30 0000001961 2024-09-30 0000001961 us-gaap:CommonStockMember 2025-09-30 0000001961 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0000001961 us-gaap:WarrantMember 2025-09-30 0000001961 us-gaap:RetainedEarningsMember 2025-09-30 0000001961 srt:MinimumMember 2025-09-30 0000001961 srt:MaximumMember 2025-09-30 0000001961 2001-04-01 0000001961 WDDD:Outstanding1Member 2025-09-30 0000001961 WDDD:Outstanding2Member 2025-09-30 0000001961 WDDD:Outstanding3Member 2025-09-30 0000001961 WDDD:Exercisable1Member 2025-09-30 0000001961 WDDD:Exercisable2Member 2025-09-30 0000001961 WDDD:Exercisable3Member 2025-09-30 0000001961 2019-08-28 0000001961 WDDD:Additionalbonus1Member 2019-08-28 0000001961 WDDD:Additionalbonus2Member 2019-08-28 0000001961 2019-08-28 2019-08-29 0000001961 2018-08-28 0000001961 2020-08-28 0000001961 2024-01-01 2024-12-31 0000001961 2011-01-01 iso4217:USD shares iso4217:USD shares utr:Y pure WDDD:Interger false 2025 Q3 --12-31 0000001961

P3Y

P5Y

10-Q true 2025-09-30 false 000-24115 GEMAXEL INC. (formerly known as Worlds Inc.) DE 22-1848316 4775 Collins Ave Apt 25088 Miami Beach FL 33140 917 270-1187 No Yes Non-accelerated Filer true false true 57112506

4629

6380

2188

8750

6817

15130

6817

15130

835813

809928

489175

316765

1821507

1768703

61610

773279

3981384

3668675

3981384

3668675

0.001

250000000

57112506

57113

42335725

1206913

-47574318

-47253296

-3974567

-3653545

6817

15130

101328

122758

4788

61971

161353

194426

40354

65128

-262681

-317184

-45142

-127099

58341

56784

20214

19127

-321022

-373968

-65355

-146226

-0.01

-0.00

57112506

57113

42335725

1206913

-46741914

-3142163

-105862

57112506

57113

42335725

1206913

-46847776

-3248025

-121880

57112506

57113

42335725

1206913

-46969656

-3369905

-146226

57112506

57113

42335725

1206913

-47115882

-3516131

57112506

57113

42335725

1206913

-47253296

-3653545

-116601

57112506

57113

42335725

1206913

-47369897

-3770146

-139067

57112506

57113

42335725

1206913

-47508964

-3909213

-65355

57112506

57113

42335725

1206913

-47574318

-3974567

-321022

-373968

6562

172410

100614

78689

59751

-63361

-213603

61610

-1751

-213603

6380

244856

4629

31253

NOTE 1 – GOING CONCERN As reflected in the accompanying financial statements, the Company has a working capital deficiency of $3,974,567 and a stockholder’s deficiency of $3,974,567 and used $63,361 of cash in operations for the nine months ended September 30, 2025. This raises substantial doubt about its ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company’s ability to raise additional capital and implement its business plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Management believes that the actions presently being taken to obtain additional funding and implement its strategic plans provide the opportunity for the Company to continue as a going concern, although no assurance can be given that the Company will be successful.

3974567

63361

NOTE 2 – DESCRIPTION OF BUSINESS AND SUMMARY OF ACCOUNTING POLICIES Description of Business On March 26, 2026, the Company changed its name from Worlds Inc. to Gemaxel Inc. On May 16, 2011, the Company transferred, through a spin-off to its then wholly owned subsidiary, Worlds Online Inc. (currently called MariMed Inc.), the majority of its operations and related operational assets. The Company retained its patent portfolio and is looking to expand on its legacy celebrity worlds and its collection of non-fungible tokens. Basis of Presentation The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("US GAAP"). The Company has incurred significant losses since its inception and has had minimal revenues from operations. The Company will require substantial additional funds for its expansion of its legacy celebrity worlds and its collection of non-fungible tokens. There can be no assurance that the Company will be able to obtain the substantial additional capital resources to pursue its business plan or that any assumptions relating to its business plan will prove to be accurate. The Company has not been able to generate sufficient revenue or obtain sufficient financing which has had a material adverse effect on the Company, including requiring the Company to reduce operations. As the Company has focused its attention historically on increasing its patent portfolio and enforcing it, and more recently on its expansion of its legacy celebrity worlds and its collection of non-fungible tokens, the Company has been operating at a reduced capacity, with only one employee and using consultants to perform any additional work that may be required. Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Cash and Cash Equivalents Cash and cash equivalents include highly liquid money market instruments, which have original maturities of three months or less at the time of purchase. Revenue Recognition Effective January 1, 2018, the Company adopted ASC 606. There was no impact in adopting ASC 606 as the Company has no revenue at this time. In the second quarter of 2011, the Company spun off its online businesses to MariMed Inc. The Company’s sources of revenue after the spinoff was expected to be from sublicenses of the patented technology by Worlds Online and any revenue that may be generated from enforcing its patents. Commencing in the first half of 2023, the Company expects that its revenues will come from the sale of it’s intellectual properties. The Company recognizes revenue by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. Advertising Expenses Advertising costs are expensed as incurred. There were no advertising costs in the nine months ended September 30, 2025 and 2024. Research and Development Costs Research and development costs are charged to operations as incurred. There were no research and development costs in the nine months ended September 30, 2025 and 2024. <p id="xdx_846_eus-gaap--ReceivablesAndPortionsOfSecuritizationsThatCanBePrepaidAtPotentialLossPolicyPolicyTextBlock_zw0HK4sVNmv3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Prepaid Expenses Prepaid expenses is an annual fee paid to the OTC which is being amortized over the life of the subscription. The balance at September 30, 2025 is $2,188. The balance at December 31, 2024 is $8,750. Property and Equipment Property and equipment are stated at cost. Depreciation is provided on a straight line basis over the estimated useful lives of the assets ranging from three to five years. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income. Maintenance and repairs are charged to expense in the period incurred. Impairment of Long-Lived Assets The Company evaluates the recoverability of its fixed assets and other assets in accordance with section 360-10-15 of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) for disclosures about Impairment or Disposal of Long-Lived Assets. Disclosure requires recognition of impairment of long-lived assets in the event the net book value of such assets exceeds its expected cash flows. If so, it is considered to be impaired and is written down to fair value, which is determined based on either discounted future cash flows or appraised values. The Company adopted the statement on inception. No impairments of these types of assets were recognized during the first nine months of 2025 and 2024. Stock-Based Compensation The Company accounts for stock-based compensation using the fair value method following the guidance set forth in section 718-10 of the FASB ASC for disclosure about Stock-Based Compensation. This section requires a public entity to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). That cost will be recognized over the period during which an employee is required to provide services in exchange for the award (usually the vesting period). No compensation cost is recognized for equity instruments for which employees do not render the requisite service. Income Taxes The Company accounts for income taxes under Section 740-10-30 of the FASB ASC. Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax basis of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the consolidated statements of operations in the period that includes the enactment date. ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts. Notes Payable The Company has $773,279 in short term notes outstanding at September 30, 2025 and December 31, 2024. These are old notes payable for which the statute of limitations has passed and therefore the Company does not expect it will ever have to repay those notes. Loan Payable Related Party During the nine months ended September 30, 2025, the Company received loans from it’s CEO to pay operating expenses. The balance at September 30, 2025 is $61,610. Interest is being accrued at seven percent. Accrued interest on the loan as of September 30, 2025 is $1,557. There were no loans from related parties at December 31, 2024. Comprehensive Income (Loss) The Company reports comprehensive income and its components following guidance set forth by section 220-10 of the FASB ASC which establishes standards for the reporting and display of comprehensive income and its components in the financial statements. There were no items of comprehensive income (loss) applicable to the Company during the period covered in the financial statements. Loss Per Share Net loss per common share is computed pursuant to section 260-10-45 of the FASB ASC. Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. As of September 30, 2025, there were 1,600,000 options and no warrants outstanding and as of September 30, 2024 there were 16,600,000 options and no warrants outstanding whose effect is anti-dilutive and not included in diluted net loss per share for September 30, 2025 or for September 30, 2024. The options and warrants may dilute future earnings per share. Commitments and Contingencies The Company follows subtopic 450-20 of the FASB ASC to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time, that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows. During 2000 the Company was involved in a lawsuit relating to unpaid consulting services. In April, 2001 a judgment against the Company was rendered for approximately $205,000. As of September 30, 2025, and December 31, 2024 the Company recorded a reserve of $205,000 for this lawsuit, which is included in accrued expenses in the accompanying balance sheets. Risk and Uncertainties The Company is subject to risks common to companies in the technology industries, including, but not limited to, litigation, development of new technological innovations and dependence on key personnel. Off Balance Sheet Arrangements The Company does not have any off-balance sheet arrangements. Uncertain Tax Positions The Company did not take any uncertain tax positions and had no adjustments to unrecognized income tax liabilities or benefits pursuant to the provisions of Section 740-10-25 for the year ended December 31, 2024. Fair Value of Financial Instruments The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level. The following are the hierarchical levels of inputs to measure fair value: <table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: right; line-height: 105%">• </td> <td style="text-align: justify; line-height: 105%">Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: right; line-height: 105%">• </td> <td style="text-align: justify; line-height: 105%">Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: right; line-height: 105%">• </td> <td style="text-align: justify; line-height: 105%">Level 3 - Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.</td></tr> </table> The carrying amounts of the Company’s financial assets and liabilities, such as cash, other receivables, accounts payable & accrued expenses, due to related party, notes payable and notes payables, approximate their fair values because of the short maturity of these instruments. The Company's convertible notes payable are measured at amortized cost. Warrant and option expense was measured by using level 3 valuation. Embedded Conversion Features The Company evaluates embedded conversion features within convertible debt under ASC 815 “Derivatives and Hedging” to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes in fair value recorded in earnings. If the conversion feature does not require derivative treatment under ASC 815, the instrument is evaluated under ASC 470-20 “Debt with Conversion and Other Options” for consideration of any beneficial conversion feature. Derivative Financial Instruments The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported as charges or credits to income. For option-based simple derivative financial instruments, the Company uses the Black-Scholes option-pricing model to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Recent Accounting Pronouncements The Company has reviewed all recently issued, but not yet effective, accounting pronouncements, and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

Description of Business On March 26, 2026, the Company changed its name from Worlds Inc. to Gemaxel Inc. On May 16, 2011, the Company transferred, through a spin-off to its then wholly owned subsidiary, Worlds Online Inc. (currently called MariMed Inc.), the majority of its operations and related operational assets. The Company retained its patent portfolio and is looking to expand on its legacy celebrity worlds and its collection of non-fungible tokens.

Basis of Presentation The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("US GAAP"). The Company has incurred significant losses since its inception and has had minimal revenues from operations. The Company will require substantial additional funds for its expansion of its legacy celebrity worlds and its collection of non-fungible tokens. There can be no assurance that the Company will be able to obtain the substantial additional capital resources to pursue its business plan or that any assumptions relating to its business plan will prove to be accurate. The Company has not been able to generate sufficient revenue or obtain sufficient financing which has had a material adverse effect on the Company, including requiring the Company to reduce operations. As the Company has focused its attention historically on increasing its patent portfolio and enforcing it, and more recently on its expansion of its legacy celebrity worlds and its collection of non-fungible tokens, the Company has been operating at a reduced capacity, with only one employee and using consultants to perform any additional work that may be required.

Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.

Cash and Cash Equivalents Cash and cash equivalents include highly liquid money market instruments, which have original maturities of three months or less at the time of purchase.

Revenue Recognition Effective January 1, 2018, the Company adopted ASC 606. There was no impact in adopting ASC 606 as the Company has no revenue at this time. In the second quarter of 2011, the Company spun off its online businesses to MariMed Inc. The Company’s sources of revenue after the spinoff was expected to be from sublicenses of the patented technology by Worlds Online and any revenue that may be generated from enforcing its patents. Commencing in the first half of 2023, the Company expects that its revenues will come from the sale of it’s intellectual properties. The Company recognizes revenue by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied.

Advertising Expenses Advertising costs are expensed as incurred. There were no advertising costs in the nine months ended September 30, 2025 and 2024.

Research and Development Costs Research and development costs are charged to operations as incurred. There were no research and development costs in the nine months ended September 30, 2025 and 2024.

<p id="xdx_846_eus-gaap--ReceivablesAndPortionsOfSecuritizationsThatCanBePrepaidAtPotentialLossPolicyPolicyTextBlock_zw0HK4sVNmv3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Prepaid Expenses Prepaid expenses is an annual fee paid to the OTC which is being amortized over the life of the subscription. The balance at September 30, 2025 is $2,188. The balance at December 31, 2024 is $8,750.

2188

8750

Property and Equipment Property and equipment are stated at cost. Depreciation is provided on a straight line basis over the estimated useful lives of the assets ranging from three to five years. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income. Maintenance and repairs are charged to expense in the period incurred.

Impairment of Long-Lived Assets The Company evaluates the recoverability of its fixed assets and other assets in accordance with section 360-10-15 of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) for disclosures about Impairment or Disposal of Long-Lived Assets. Disclosure requires recognition of impairment of long-lived assets in the event the net book value of such assets exceeds its expected cash flows. If so, it is considered to be impaired and is written down to fair value, which is determined based on either discounted future cash flows or appraised values. The Company adopted the statement on inception. No impairments of these types of assets were recognized during the first nine months of 2025 and 2024.

Stock-Based Compensation The Company accounts for stock-based compensation using the fair value method following the guidance set forth in section 718-10 of the FASB ASC for disclosure about Stock-Based Compensation. This section requires a public entity to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). That cost will be recognized over the period during which an employee is required to provide services in exchange for the award (usually the vesting period). No compensation cost is recognized for equity instruments for which employees do not render the requisite service.

Income Taxes The Company accounts for income taxes under Section 740-10-30 of the FASB ASC. Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax basis of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the consolidated statements of operations in the period that includes the enactment date. ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

0.50

Notes Payable The Company has $773,279 in short term notes outstanding at September 30, 2025 and December 31, 2024. These are old notes payable for which the statute of limitations has passed and therefore the Company does not expect it will ever have to repay those notes.

773279

Loan Payable Related Party During the nine months ended September 30, 2025, the Company received loans from it’s CEO to pay operating expenses. The balance at September 30, 2025 is $61,610. Interest is being accrued at seven percent. Accrued interest on the loan as of September 30, 2025 is $1,557. There were no loans from related parties at December 31, 2024.

61610

1557

Comprehensive Income (Loss) The Company reports comprehensive income and its components following guidance set forth by section 220-10 of the FASB ASC which establishes standards for the reporting and display of comprehensive income and its components in the financial statements. There were no items of comprehensive income (loss) applicable to the Company during the period covered in the financial statements.

Loss Per Share Net loss per common share is computed pursuant to section 260-10-45 of the FASB ASC. Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. As of September 30, 2025, there were 1,600,000 options and no warrants outstanding and as of September 30, 2024 there were 16,600,000 options and no warrants outstanding whose effect is anti-dilutive and not included in diluted net loss per share for September 30, 2025 or for September 30, 2024. The options and warrants may dilute future earnings per share.

1600000

16600000

Commitments and Contingencies The Company follows subtopic 450-20 of the FASB ASC to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time, that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows. During 2000 the Company was involved in a lawsuit relating to unpaid consulting services. In April, 2001 a judgment against the Company was rendered for approximately $205,000. As of September 30, 2025, and December 31, 2024 the Company recorded a reserve of $205,000 for this lawsuit, which is included in accrued expenses in the accompanying balance sheets.

205000

Risk and Uncertainties The Company is subject to risks common to companies in the technology industries, including, but not limited to, litigation, development of new technological innovations and dependence on key personnel.

Off Balance Sheet Arrangements The Company does not have any off-balance sheet arrangements.

Uncertain Tax Positions The Company did not take any uncertain tax positions and had no adjustments to unrecognized income tax liabilities or benefits pursuant to the provisions of Section 740-10-25 for the year ended December 31, 2024.

Fair Value of Financial Instruments The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level. The following are the hierarchical levels of inputs to measure fair value: <table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: right; line-height: 105%">• </td> <td style="text-align: justify; line-height: 105%">Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: right; line-height: 105%">• </td> <td style="text-align: justify; line-height: 105%">Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: right; line-height: 105%">• </td> <td style="text-align: justify; line-height: 105%">Level 3 - Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.</td></tr> </table> The carrying amounts of the Company’s financial assets and liabilities, such as cash, other receivables, accounts payable & accrued expenses, due to related party, notes payable and notes payables, approximate their fair values because of the short maturity of these instruments. The Company's convertible notes payable are measured at amortized cost. Warrant and option expense was measured by using level 3 valuation.

Embedded Conversion Features The Company evaluates embedded conversion features within convertible debt under ASC 815 “Derivatives and Hedging” to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes in fair value recorded in earnings. If the conversion feature does not require derivative treatment under ASC 815, the instrument is evaluated under ASC 470-20 “Debt with Conversion and Other Options” for consideration of any beneficial conversion feature.

Derivative Financial Instruments The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported as charges or credits to income. For option-based simple derivative financial instruments, the Company uses the Black-Scholes option-pricing model to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.

Recent Accounting Pronouncements The Company has reviewed all recently issued, but not yet effective, accounting pronouncements, and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

NOTE 3 - NOTES PAYABLE <table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zpqHeWOklZ33" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Notes Payable - (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: center">Notes payable at September 30, 2025 consist of the following:</td> <td> </td> <td colspan="3" id="xdx_49D_20250930_zUoU2Wl1Zzt9"> </td></tr> <tr id="xdx_407_eus-gaap--NotesPayable_iI_zc9PAxHZn8P5" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%">Unsecured note payable bearing 8% interest, entire balance of principal and unpaid interest due on demand</td> <td style="width: 5%"> </td> <td style="width: 1%">$</td> <td style="width: 31%; text-align: right">124,230</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr id="xdx_401_eus-gaap--NotesAndLoansPayable_iI_zTcLMKcbgv6f" style="vertical-align: bottom; background-color: #CCEEFF"> <td>Unsecured note payable bearing 10% interest, entire balance of principal and unpaid interest due on demand</td> <td> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">649,049</td> <td> </td></tr> <tr id="xdx_409_eus-gaap--NotesPayableCurrent_iI_zChWujg0kbPd" style="vertical-align: bottom; background-color: white"> <td>Total notes</td> <td> </td> <td style="border-bottom: Black 2.5pt double; vertical-align: middle; font-size: 11pt; color: Black; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 11pt; color: Black; text-align: right">773,279</td> <td> </td></tr> <tr id="xdx_401_eus-gaap--FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths_iI_maNPCz2IB_zGUcW3F1q7N" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: center">2025 (3 months remaining)</td> <td> </td> <td>$</td> <td style="text-align: right">773,279</td> <td> </td></tr> <tr id="xdx_406_eus-gaap--FinanceLeaseLiabilityPaymentsDueInRollingYearTwo_iI_maNPCz2IB_zIOvVkwlvGyg" style="vertical-align: bottom; background-color: white"> <td style="text-align: center">2026</td> <td> </td> <td>$</td> <td style="text-align: right">- 0 -</td> <td> </td></tr> <tr id="xdx_405_eus-gaap--FinanceLeaseLiabilityPaymentsDueInRollingYearThree_iI_maNPCz2IB_zWqv9gGgSEda" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: center">2027</td> <td> </td> <td>$</td> <td style="text-align: right">- 0 -</td> <td> </td></tr> <tr id="xdx_409_eus-gaap--FinanceLeaseLiabilityPaymentsDueInRollingYearFour_iI_maNPCz2IB_ztHIsEOzO7g5" style="vertical-align: bottom; background-color: white"> <td style="text-align: center">2028</td> <td> </td> <td>$</td> <td style="text-align: right">- 0 -</td> <td> </td></tr> <tr id="xdx_404_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_maNPCz2IB_zjffBdogG5zi" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: center">2029</td> <td> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">- 0 -</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td style="border-bottom: Black 2.5pt double; vertical-align: middle; font-size: 11pt; color: Black; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 11pt; color: Black; text-align: right">773,279</td> <td> </td></tr> </table> The Company accrued interest of $56,784 on the notes during the nine months ended September 30, 2025.

<table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zpqHeWOklZ33" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Notes Payable - (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: center">Notes payable at September 30, 2025 consist of the following:</td> <td> </td> <td colspan="3" id="xdx_49D_20250930_zUoU2Wl1Zzt9"> </td></tr> <tr id="xdx_407_eus-gaap--NotesPayable_iI_zc9PAxHZn8P5" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%">Unsecured note payable bearing 8% interest, entire balance of principal and unpaid interest due on demand</td> <td style="width: 5%"> </td> <td style="width: 1%">$</td> <td style="width: 31%; text-align: right">124,230</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr id="xdx_401_eus-gaap--NotesAndLoansPayable_iI_zTcLMKcbgv6f" style="vertical-align: bottom; background-color: #CCEEFF"> <td>Unsecured note payable bearing 10% interest, entire balance of principal and unpaid interest due on demand</td> <td> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">649,049</td> <td> </td></tr> <tr id="xdx_409_eus-gaap--NotesPayableCurrent_iI_zChWujg0kbPd" style="vertical-align: bottom; background-color: white"> <td>Total notes</td> <td> </td> <td style="border-bottom: Black 2.5pt double; vertical-align: middle; font-size: 11pt; color: Black; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 11pt; color: Black; text-align: right">773,279</td> <td> </td></tr> <tr id="xdx_401_eus-gaap--FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths_iI_maNPCz2IB_zGUcW3F1q7N" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: center">2025 (3 months remaining)</td> <td> </td> <td>$</td> <td style="text-align: right">773,279</td> <td> </td></tr> <tr id="xdx_406_eus-gaap--FinanceLeaseLiabilityPaymentsDueInRollingYearTwo_iI_maNPCz2IB_zIOvVkwlvGyg" style="vertical-align: bottom; background-color: white"> <td style="text-align: center">2026</td> <td> </td> <td>$</td> <td style="text-align: right">- 0 -</td> <td> </td></tr> <tr id="xdx_405_eus-gaap--FinanceLeaseLiabilityPaymentsDueInRollingYearThree_iI_maNPCz2IB_zWqv9gGgSEda" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: center">2027</td> <td> </td> <td>$</td> <td style="text-align: right">- 0 -</td> <td> </td></tr> <tr id="xdx_409_eus-gaap--FinanceLeaseLiabilityPaymentsDueInRollingYearFour_iI_maNPCz2IB_ztHIsEOzO7g5" style="vertical-align: bottom; background-color: white"> <td style="text-align: center">2028</td> <td> </td> <td>$</td> <td style="text-align: right">- 0 -</td> <td> </td></tr> <tr id="xdx_404_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_maNPCz2IB_zjffBdogG5zi" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: center">2029</td> <td> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">- 0 -</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td style="border-bottom: Black 2.5pt double; vertical-align: middle; font-size: 11pt; color: Black; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 11pt; color: Black; text-align: right">773,279</td> <td> </td></tr> </table>

124230

649049

773279

-0

56784

NOTE 4 - EQUITY The Company did not issue any shares of common stock, options or warrants in the nine months ending September 30, 2025 or in the nine months ending September 30, 2024. <table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock_zHoqFdw0QIph" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock Warrants and Options - (Details)"> <tr style="vertical-align: bottom"> <td colspan="3" id="xdx_488_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_zozlslb99zz1" style="font-size: 11pt"> </td><td> </td> <td colspan="3" id="xdx_48C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_zhcGd6HcWvMe"> </td><td> </td> <td colspan="3" id="xdx_489_ecustom--RemainingLifeInYears_iI_zgs8hE9lEbWc"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="font-size: 11pt"></td><td colspan="5" style="text-align: center">Stock Warrants and Options</td> <td colspan="3"></td></tr> <tr style="vertical-align: bottom"> <td colspan="11" style="font: 11pt Times New Roman, Times, Serif; text-align: center">Stock warrants/options outstanding and exercisable on September 30, 2025 are as follows</td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="font: 11pt Times New Roman, Times, Serif"> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="font-size: 11pt; text-align: center">Exercise Price per Share</td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 11pt; text-align: center">Shares Under Option/warrant</td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 11pt; text-align: center">Remaining Life in Years</td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="font-size: 11pt; text-align: center"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 11pt; text-align: center"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 11pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td colspan="3" style="font-size: 11pt">Outstanding</td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr id="xdx_41E_20250930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Outstanding1Member_z1qDMcL75T0a" style="vertical-align: bottom; background-color: White"> <td style="width: 1%; font-size: 11pt; text-align: left">$</td><td style="width: 26%; font-size: 11pt; text-align: right">0.27</td><td style="width: 1%; font-size: 11pt; text-align: left"> </td><td style="width: 8%; font-size: 11pt"> </td> <td style="width: 1%; font-size: 11pt; text-align: left"> </td><td style="width: 26%; font-size: 11pt; text-align: right">300,000</td><td style="width: 1%; font-size: 11pt; text-align: left"> </td><td style="width: 8%; font-size: 11pt"> </td> <td style="width: 1%; font-size: 11pt; text-align: left"> </td><td style="width: 26%; font-size: 11pt; text-align: right">0.13</td><td style="width: 1%; font-size: 11pt; text-align: left"> </td></tr> <tr id="xdx_41D_20250930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Outstanding2Member_zjQGtQhCJ5G8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 11pt; text-align: left">$</td><td style="font-size: 11pt; text-align: right">0.05</td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right">600,000</td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right">1.26</td><td style="font-size: 11pt; text-align: left"> </td></tr> <tr id="xdx_414_20250930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Outstanding3Member_zv1UXbVgL49i" style="vertical-align: bottom; background-color: White"> <td style="font-size: 11pt; text-align: left">$</td><td style="font-size: 11pt; text-align: right">0.08</td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right">700,000</td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right">1.38</td><td style="font-size: 11pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td colspan="2" style="font-size: 11pt; text-align: left">Total </td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right">1,600,000</td><td style="font-size: 11pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right"> </td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right"> </td><td style="font-size: 11pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td colspan="2" style="font-size: 11pt; text-align: left">Exercisable </td><td style="font-size: 11pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_41F_20250930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Exercisable1Member_zjbenDaTugK5" style="vertical-align: bottom; background-color: White"> <td style="font-size: 11pt; text-align: left">$</td><td style="font-size: 11pt; text-align: right">0.27</td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right">300,000</td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right">0.13</td><td style="font-size: 11pt; text-align: left"> </td></tr> <tr id="xdx_412_20250930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Exercisable2Member_zd0nOZClzii1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 11pt; text-align: left">$</td><td style="font-size: 11pt; text-align: right">0.05</td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right">600,000</td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right">1.26</td><td style="font-size: 11pt; text-align: left"> </td></tr> <tr id="xdx_41C_20250930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Exercisable3Member_zxAwhOUzIRt8" style="vertical-align: bottom; background-color: White"> <td style="font-size: 11pt; text-align: left">$</td><td style="font-size: 11pt; text-align: right">0.08</td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right">700,000</td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right">1.38</td><td style="font-size: 11pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td colspan="2" style="font-size: 11pt; text-align: left">Total </td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right">1,600,000</td><td style="font-size: 11pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> </table>

<table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock_zHoqFdw0QIph" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock Warrants and Options - (Details)"> <tr style="vertical-align: bottom"> <td colspan="3" id="xdx_488_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_zozlslb99zz1" style="font-size: 11pt"> </td><td> </td> <td colspan="3" id="xdx_48C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_zhcGd6HcWvMe"> </td><td> </td> <td colspan="3" id="xdx_489_ecustom--RemainingLifeInYears_iI_zgs8hE9lEbWc"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="font-size: 11pt"></td><td colspan="5" style="text-align: center">Stock Warrants and Options</td> <td colspan="3"></td></tr> <tr style="vertical-align: bottom"> <td colspan="11" style="font: 11pt Times New Roman, Times, Serif; text-align: center">Stock warrants/options outstanding and exercisable on September 30, 2025 are as follows</td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="font: 11pt Times New Roman, Times, Serif"> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="font-size: 11pt; text-align: center">Exercise Price per Share</td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 11pt; text-align: center">Shares Under Option/warrant</td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 11pt; text-align: center">Remaining Life in Years</td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="font-size: 11pt; text-align: center"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 11pt; text-align: center"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 11pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td colspan="3" style="font-size: 11pt">Outstanding</td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr id="xdx_41E_20250930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Outstanding1Member_z1qDMcL75T0a" style="vertical-align: bottom; background-color: White"> <td style="width: 1%; font-size: 11pt; text-align: left">$</td><td style="width: 26%; font-size: 11pt; text-align: right">0.27</td><td style="width: 1%; font-size: 11pt; text-align: left"> </td><td style="width: 8%; font-size: 11pt"> </td> <td style="width: 1%; font-size: 11pt; text-align: left"> </td><td style="width: 26%; font-size: 11pt; text-align: right">300,000</td><td style="width: 1%; font-size: 11pt; text-align: left"> </td><td style="width: 8%; font-size: 11pt"> </td> <td style="width: 1%; font-size: 11pt; text-align: left"> </td><td style="width: 26%; font-size: 11pt; text-align: right">0.13</td><td style="width: 1%; font-size: 11pt; text-align: left"> </td></tr> <tr id="xdx_41D_20250930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Outstanding2Member_zjQGtQhCJ5G8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 11pt; text-align: left">$</td><td style="font-size: 11pt; text-align: right">0.05</td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right">600,000</td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right">1.26</td><td style="font-size: 11pt; text-align: left"> </td></tr> <tr id="xdx_414_20250930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Outstanding3Member_zv1UXbVgL49i" style="vertical-align: bottom; background-color: White"> <td style="font-size: 11pt; text-align: left">$</td><td style="font-size: 11pt; text-align: right">0.08</td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right">700,000</td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right">1.38</td><td style="font-size: 11pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td colspan="2" style="font-size: 11pt; text-align: left">Total </td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right">1,600,000</td><td style="font-size: 11pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right"> </td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right"> </td><td style="font-size: 11pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td colspan="2" style="font-size: 11pt; text-align: left">Exercisable </td><td style="font-size: 11pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_41F_20250930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Exercisable1Member_zjbenDaTugK5" style="vertical-align: bottom; background-color: White"> <td style="font-size: 11pt; text-align: left">$</td><td style="font-size: 11pt; text-align: right">0.27</td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right">300,000</td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right">0.13</td><td style="font-size: 11pt; text-align: left"> </td></tr> <tr id="xdx_412_20250930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Exercisable2Member_zd0nOZClzii1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 11pt; text-align: left">$</td><td style="font-size: 11pt; text-align: right">0.05</td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right">600,000</td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right">1.26</td><td style="font-size: 11pt; text-align: left"> </td></tr> <tr id="xdx_41C_20250930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Exercisable3Member_zxAwhOUzIRt8" style="vertical-align: bottom; background-color: White"> <td style="font-size: 11pt; text-align: left">$</td><td style="font-size: 11pt; text-align: right">0.08</td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right">700,000</td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right">1.38</td><td style="font-size: 11pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td colspan="2" style="font-size: 11pt; text-align: left">Total </td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right">1,600,000</td><td style="font-size: 11pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> </table>

0.27

300000

0.13

0.05

600000

1.26

0.08

700000

1.38

0.27

300000

0.13

0.05

600000

1.26

0.08

700000

1.38

NOTE 5 - COMMITMENTS AND CONTINGENCIES The Company was committed to an employment agreement with its President and CEO, Thom Kidrin. The agreement, dated as of August 28, 2018, was for five years with one-year renewal options held by Mr. Kidrin. Prior to its expiration, Mr. Kidrin agreed to a one year extension of his employment agreement. Mr. Kidrin agreed to an additional one year extension in 2024. The agreement expired without being renewed in August 2025. The agreement provided for a base salary of $200,000, which increases 10% on September 1 of each year; a monthly car allowance of $500; an annual bonus equal to 2.5% of Pre-Tax Income (as defined in the agreement); an additional bonus as follows: $75,000, if Pre-Tax Income for the year is between 150% and 200% of the prior fiscal year’s Pre-Tax Income or (B) $100,000, if Pre-Tax Income for the year is between 201% and 250% of the prior fiscal year’s Pre-Tax Income or (C) $200,000, if Pre-Tax Income for the year is 251% or greater than the prior fiscal year’s Pre-Tax Income, but in no event shall this additional bonus exceed five (5%) percent of Pre-Tax Income for such year; payment of up to $10,000 in life insurance premiums; options to purchase 5 million shares of Worlds Inc. common stock at an exercise price of $0.25 per share, 2 million of which vested on August 28, 2018, 1.5 million vested on August 28, 2019 and the remaining 1.5 million vested on August 28, 2020 and a death benefit of at least $2 million dollars; and a payment equal to 2.99 times his base amount (as defined in the agreement) in the event of a Change of Control (as defined in the agreement). The agreement also provided that Mr. Kidrin could be terminated for cause (as defined in the agreement) and that he is subject to restrictive covenants for 12 months after termination.

5 1 one year 200000

500 0.025 75000 1.50 2 100000 2.01 2.50 200000 2.51 0.05

10000

5000000

0.25

2000000

1500000 1500000

2000000

2.99 12

NOTE 6 - RELATED PARTY TRANSACTIONS During the nine months ended September 30, 2025, Mr. Kidrin the CEO of the Company loaned the Company $61,610 to cover operating expenses. The balance as of September 30, 2025 is $61,610. The balance in the accrued expense attributable to related parties is comprised of accrued salary due the CEO based on an employment agreement for $389,431, $161,354 increase from the December 31, 2024 balance and an accrued consulting fee to the CFO in the amount of $98,188, an increase of $9,500 in the nine months ended September 30, 2025. The balance is accrued interest on the loan from the CEO in the amount of $1,557 for a total of $489,176 at September 30, 2025. The balance in the accrued expense attributable to related parties at December 31, 2024 is comprised of accrued salary due the CEO based on an employment agreement for $228,077 and an accrued consulting fee to the CFO in the amount of $88,688 for a total of $316,765 at December 31, 2024.

61610

389431

161354

98188

9500

1557

489176

228077

88688

316765

NOTE 7 – ACCRUED EXPENSES Accrued expenses is comprised of (i) $489,176 owed to related parties, (ii) $205,000 related to a judgment against the Company relating to unpaid consulting services dating back to April of 2001, for which collection has not been sought in two decades so the Company does not expect it will ever have to pay it, (iii) $1,589,470 related to old accruals for which the statute of limitations has passed and therefore the Company does not expect it will ever have to repay those amounts, (iv) $9,256 related to accruals for recurring operating expenses, and (v) $17,780 related to a judgement requiring the Company to reimburse litigation fees.

489176

205000

1589470

9256

17780

NOTE 8 – PREPAID EXPENSES Prepaid expenses is an annual fee paid to the OTC and being amortized over the life of the subscription. The balance at September 30, 2025 is $2,188. The balance at December 31, 2024 is $8,750.

2188

8750

NOTE 9 – SALE OF MARKETABLE SECURITIES When Gemaxel Inc. spun off Worlds Online Inc. in January 2011, the Company retained 5,936,115 shares of common stock in Worlds Online Inc. (now named MariMed Inc.). Those shares were retained on the books of the Company with a book value of $0. During the nine months ended September 30, 2025, there were no sales of stock. During the nine months ended September 30, 2024, there were no sales of stock. As of September 30, 2025, the Company still owns approximately 350,000 shares of MariMed Inc. common stock.

5936115 0

350000

NOTE 10 – SUBSEQUENT EVENTS In November of 2025 the CEO and Chairman of the Board, Thom Kidrin passed away. Director Leonard Toboroff was named acting CEO and Chairman of the Board of the Company. The Company changed its name to Gemaxel Inc. in the 2nd quarter of 2026. The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements.